Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions - PubMed (original) (raw)
Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions
G M Pasinetti et al. Neurobiol Dis. 1996.
Abstract
Possible roles of the complement (C) system in the normal and injured brain were explored with inbred mice that carried a frameshift mutation in the C5 gene. A congenic pair was used: the C5-sufficient (C5+) B10.D2/nSnJ strain with the functional allele (Hc1) from the C57BL/10J donor strain was compared with the C5-deficient (C5-) B10.D2/oSnJ with the Hc0 allele from the C5-deficient DBA/2J donor strain. In response to the excitotoxin kainic acid (KA), C5- mice had more hippocampal pyramidal neuron death and greater induction of astrocyte mRNAs (GFAP, apoE, apoJ). In primary astrocyte cultures from unlesioned mice, an inflammatory stimulus (LPS) caused greater production of IL-6 and TNF production in C5- mice. These enhanced responses to KA and LPS suggest that hereditary C5 deficits modify responses to neurodegenerative stimuli of neurons and astrocytes. Moreover, unlesioned C5- mice had smaller input-output slopes for the NMDA component of the EPSP amplitude, but enhanced the Ca(+2)-dependent AMPA binding. Thus, C5 deficits also modify basal properties of glutamatergic neurotransmission that pertain to synaptic plasticity. These findings are also discussed in relation to roles of the C-system in Alzheimer disease (AD). C5 deficiencies may also be considered in the choice of strains as transgene hosts and for genetic analysis of normal and pathological brain functions. In recent transgenic studies for AD, C5- hosts showed greater neurodegeneration, consistent with the present data. These pleiotropic associations of C5 deficiency indicate roles for the C-system in neurodegeneration, but also in normal neural functions.
Similar articles
- Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.
Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL. Samland H, et al. J Neurosci Res. 2003 Jul 15;73(2):176-87. doi: 10.1002/jnr.10635. J Neurosci Res. 2003. PMID: 12836160 - Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM, Benjamin DK Jr, Hester CG, Frank MM. Cunnion KM, et al. J Lab Clin Med. 2004 Jun;143(6):358-65. doi: 10.1016/j.lab.2004.03.005. J Lab Clin Med. 2004. PMID: 15192652 - Hereditary absence of complement C5 in adult mice influences Wallerian degeneration, but not retrograde responses, following injury to peripheral nerve.
Liu L, Lioudyno M, Tao R, Eriksson P, Svensson M, Aldskogius H. Liu L, et al. J Peripher Nerv Syst. 1999;4(2):123-33. J Peripher Nerv Syst. 1999. PMID: 10442688 - Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice.
Otani N, Nawashiro H, Fukui S, Ooigawa H, Ohsumi A, Toyooka T, Shima K, Gomi H, Brenner M. Otani N, et al. J Clin Neurosci. 2006 Nov;13(9):934-8. doi: 10.1016/j.jocn.2005.10.018. J Clin Neurosci. 2006. PMID: 17085299
Cited by
- Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.
Cox MM, Tucker AM, Tang J, Talbot K, Richer DC, Yeh L, Arnold SE. Cox MM, et al. Genes Brain Behav. 2009 Jun;8(4):390-7. doi: 10.1111/j.1601-183X.2009.00477.x. Epub 2009 Feb 11. Genes Brain Behav. 2009. PMID: 19220483 Free PMC article. - Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury.
Galvan MD, Luchetti S, Burgos AM, Nguyen HX, Hooshmand MJ, Hamers FP, Anderson AJ. Galvan MD, et al. J Neurosci. 2008 Dec 17;28(51):13876-88. doi: 10.1523/JNEUROSCI.2823-08.2008. J Neurosci. 2008. PMID: 19091977 Free PMC article. - Neuroinflammatory processes in Alzheimer's disease.
Heneka MT, O'Banion MK, Terwel D, Kummer MP. Heneka MT, et al. J Neural Transm (Vienna). 2010 Aug;117(8):919-47. doi: 10.1007/s00702-010-0438-z. Epub 2010 Jul 15. J Neural Transm (Vienna). 2010. PMID: 20632195 Review. - Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA. Maier M, et al. J Neurosci. 2008 Jun 18;28(25):6333-41. doi: 10.1523/JNEUROSCI.0829-08.2008. J Neurosci. 2008. PMID: 18562603 Free PMC article. - Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ. Zhou J, et al. J Neurochem. 2008 Sep;106(5):2080-92. doi: 10.1111/j.1471-4159.2008.05558.x. Epub 2008 Jul 9. J Neurochem. 2008. PMID: 18624920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous